Apellis Pharmaceuticals Inc (APLS)
23.41
-0.35
(-1.47%)
USD |
NASDAQ |
Mar 26, 11:58
Apellis Pharmaceuticals Price to Book Value: 12.86 for March 26, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Macrogenics Inc | 0.8752 |
| Salarius Pharmaceuticals Inc | 1.006 |
| Y-mAbs Therapeutics Inc | 2.320 |
| Akero Therapeutics Inc | 4.499 |
| Recursion Pharmaceuticals Inc | 2.397 |
Price to Book Value Related Metrics
| PS Ratio | 3.712 |
| Price | 23.41 |
| Earnings Yield | -6.79% |
| Market Cap | 2.938B |